CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	2 Months Ended	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2015	Jan. 31, 2014
Revenues:
Net revenues	$ 2,336,522	$ 32,989,742	$ 10,484,305
Costs and expenses
Cost of services	2,050,913	22,067,421	9,076,213
General and administrative	826,870	11,282,221	5,286,610
Depreciation and amortization	5,765	334,434	31,361
Total costs and expenses	2,883,548	33,684,076	14,394,184
Loss from operations	(547,026)	(694,334)	(3,909,879)
Other (expense) income
Interest expense	(184,578)	(1,326,407)	(679,184)
Gain on change in fair value of warrant and conversion feature liabilities	0	833,545	0
Other	28,816	3,031	49,702
Total other expense	(155,762)	(489,831)	(629,482)
Loss before provision for income taxes	(702,788)	(1,184,165)	(4,539,361)
Provision for income taxes	7,820	163,792	19,513
Net loss	(710,608)	(1,347,957)	(4,558,874)
Net income attributable to noncontrolling interests	(55,834)	(454,644)	(461,424)
Net loss attributable to Apollo Medical Holdings, Inc.	$ (766,442)	$ (1,802,601)	$ (5,020,298)
NET LOSS PER SHARE:
BASIC AND DILUTED	$ (0.16)	$ (0.37)	$ (1.37)
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING:
BASIC AND DILUTED	4,717,521	4,891,652	3,666,165